Aurobindo Pharma Share Price in 1997: Chart, Monthly Trends, & Analysis

How did Aurobindo Pharma shares perform in 1997?

Let's find out!

Aurobindo Pharma share price in 1997 was ₹5.43 Its price on 1st January 1997 was ₹3.4, and by 31st December 1997 it moved to ₹5.43, giving a positive return of 59.7% for the year.

Aurobindo Pharma Share Open, High, Low, and Close prices for the Year 1997 are as follows:

Open	High	Low	Close
₹3.4	₹5.64	₹2.95	₹5.43
1st Jan 1997	Occured in Aug 1997	Occured in Apr 1997	31st Dec 1997

This page will help you understand how Aurobindo Pharma performed in 1997. Let's get started.

For complete insights into Aurobindo Pharma’s incredible stock price performance and growth, see: Aurobindo Pharma Historical Share Price Data from its IPO to 2026

Table: Aurobindo Pharma Share Monthly Close, Low, High Prices for 1997

Month	Aurobindo Pharma	Change%	↑High - ↓Low
Jan	₹3.25	-	↑ ₹3.85 ↓ ₹3.21
Feb	₹3.45	6.1%	↑ ₹3.5 ↓ ₹3.16
Mar	₹3.26	-5.6%	↑ ₹4.55 ↓ ₹3.26
Apr	₹3.64	11.6%	↑ ₹3.74 ↓ ₹2.95
May	₹4.41	21.1%	↑ ₹4.79 ↓ ₹3.5
Jun	₹4.09	-7.1%	↑ ₹4.8 ↓ ₹3.73
Jul	₹5.18	26.3%	↑ ₹5.18 ↓ ₹3.7
Aug	₹4.2	-19%	↑ ₹5.64 ↓ ₹4.15
Sep	₹3.55	-15.5%	↑ ₹4.2 ↓ ₹3.42
Oct	₹3.89	9.5%	↑ ₹3.94 ↓ ₹3.35
Nov	₹3.99	2.5%	↑ ₹4.24 ↓ ₹3.68
Dec	₹5.43	36%	↑ ₹5.58 ↓ ₹3.8

Chart: CandleStick and Line Chart Showing Monthly Prices

[Click on line name to show/hide a line]

What if You invested ₹10,000 in Aurobindo Pharma in 1997?

In 1997, the opening price of Aurobindo Pharma share was ₹3.40. Today, the price stands at ₹1,472.8, reflecting a growth of 43,217.64%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 1997 would have become ₹43.31 Lakh by 2026. This represents a CAGR of 23.29%.

---

You might also like to check: Aurobindo Pharma Stock Price in 1996 or Aurobindo Pharma Stock Price in 1998

---

References: Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.

Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.